Your browser doesn't support javascript.
loading
Efficacy and safety of daratumumab in pure red cell aplasia after allogeneic transplantation: Dutch real-world data.
Weverling, Flores; Roeven, Mieke; Nijssen, Clara; Broers, Annoek E C; Dovern, Elisabeth; van Rhenen, Anna; Sluis, Geerte van; Hazenberg, Carin L E; Balen, Peter van; Kuipers, Maria T; de Vooght, Karen M K; Morsink, Linde; Kuball, Jürgen; Nur, Erfan; de Witte, Moniek A.
Afiliación
  • Weverling F; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Roeven M; Department of Hematology, Radboud University Medical Center; Nijmegen, The Netherlands.
  • Nijssen C; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Broers AEC; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Dovern E; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • van Rhenen A; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Sluis GV; Department of Hematology, Isala Hospital, Zwolle, The Netherlands.
  • Hazenberg CLE; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Balen PV; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.
  • Kuipers MT; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • de Vooght KMK; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Morsink L; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.
  • Kuball J; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Nur E; Department of Hematology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • de Witte MA; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Blood Adv ; 8(7): 1683-1686, 2024 Apr 09.
Article en En | MEDLINE | ID: mdl-38231018

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aplasia Pura de Células Rojas Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Aplasia Pura de Células Rojas Límite: Humans Idioma: En Revista: Blood Adv Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos